- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01246297
Effect of Pulmonary Rehabilitation in Lung Cancer Survivors
A Pilot Study of Early Outpatient Pulmonary Rehabilitation Following Thoracic Surgery for Lung Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The research question is to investigate
- whether patients who have undergone curative surgical resection for lung cancer benefit from 8 weeks of early outpatient pulmonary rehabilitation (started within 2 weeks of hospital discharge).
- to identify potential barriers to this approach
Pulmonary rehabilitation (PR) is the most effective non-pharmacological treatment for patients with chronic respiratory diseases, especially COPD. Many patients with lung cancer have co-existing smoking-related lung disorders such as COPD. To date there have been no randomised controlled trials of PR in post-resection lung cancer survivors. However there is indirect evidence that PR may be of benefit in this patient cohort. Cesario et al (2007)reported a 32% improvement in exercise capacity with in-patient PR, and Spruit et al (2009) demonstrated a 43% improvement in six minute walk distance following an 8-week in-patient PR programme. However, both studies had small numbers, and no randomised control group. Furthermore, inpatient PR is not an economically justifiable intervention in the NHS where emphasis is on self-management and ambulatory care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, W21NY
- Imperial College Healthcare Trust
-
-
Middlesex
-
Harefield, Middlesex, United Kingdom, UB9 6JH
- Harefield Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients undergoing lung cancer surgery with curative intent.
Exclusion Criteria:
- Unstable cardiovascular disease Severe musculo-skeletal problems that would limit exercise training(neuromuscular disorders, severe joint arthritis of lower limbs) Severe peripheral vascular disease Unable to walk 10 metres unaided Patients unable to give informed consent Recent (within 3 months of completing treatment) or untreated pulmonary TB, Untreated/uncontrolled diabetes or epilepsy Recent or recurrent untreated spontaneous pneumothorax
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control
Usual Care
|
Usual post operative care for post lung lobectomy patients for 8 weeks post discharge.
|
|
Active Comparator: Pulmonary Rehabilitation
Pulmonary Rehabilitation consists of twice weekly exercise classes with an educational component.
|
Twice weekly exercise classes with an education component.
For 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Six minute walk test to assess exercise tolerance
Time Frame: Within 3 month of discharge from surgery
|
Within 3 month of discharge from surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Shoulder Range of Motion Changes
Time Frame: Within 3 months of discharge from surgery
|
Within 3 months of discharge from surgery
|
|
Bioimpedence for tissue composition
Time Frame: Within 3 months of discharge from surgery
|
Within 3 months of discharge from surgery
|
|
Quality of life measurement changes
Time Frame: Within 3 months of discharge from surgery
|
Within 3 months of discharge from surgery
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sarah Elkin, FRCP, Imperial College Healthcare Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JROSM0090
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.